Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 10/20 | 0.46 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.40 |
| ▸ | PRMT3 | O60678 | 5/20 | 0.39 |
| ▸ | CDK2 | P24941 | 3/20 | 0.39 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.39 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | IKBKB | O14920 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1266869 | 0.77 | PRKCZ (0.46) | AKT1ROCK1PRKCZSLC6A2SLC6A4 | |
| SCHEMBL30087223 | 0.77 | PRKCZ (0.46) | AKT1ROCK1PRKCZSLC6A2SLC6A4 | |
| SCHEMBL24040173 | 0.74 | CYP19A1 (0.40) | AKT1ROCK1 | |
| SCHEMBL13877544 | 0.74 | ROCK2 (0.43) | AKT1ROCK1PRKCZ | |
| SCHEMBL3128980 | 0.74 | UGT2B7 (0.58) | ROCK1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL18823394 | 0.73 | CYP19A1 (0.49) | AKT1ROCK1 | |
| SCHEMBL30978865 | 0.72 | SLC6A3 (0.40) | ROCK1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL21422239 | 0.72 | SLC6A3 (0.40) | ROCK1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL28596057 | 0.72 | UGT2B7 (0.55) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL3311589 | 0.72 | ROCK1 (0.54) | AKT1ROCK1CDK2PRKCZIKBKB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200111977-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-04-09 | — | — | US | disclosed |
| US-20200071346-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200071346-A1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | ORC3, ORMDL3, OR10J3 | AKT1 4523/4885ROCK1 2570/4885PRMT3 208/4885 |
| US-20200111977-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | ORC3, ORMDL3, OR10J3 | AKT1 4808/4885ROCK1 4244/4885PRMT3 1050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.